SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001764013-24-000114
Filing Date
2024-06-26
Accepted
2024-06-26 06:56:24
Documents
5
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A imvt-20240331defproxy.htm DEF 14A 582077
2 GRAPHIC immunovantinc_vxprxyxgt20x.jpg GRAPHIC 497560
3 GRAPHIC immunovantinc_vxprxyxgt20xa.jpg GRAPHIC 240673
4 GRAPHIC table-capvsnl2024.jpg GRAPHIC 68137
5 GRAPHIC table-capvstsr2024.jpg GRAPHIC 73806
  Complete submission text file 0001764013-24-000114.txt   1795234
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-38906 | Film No.: 241070593
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)